linagliptin intas 5 mg tabletki powlekane
intas third party sales 2005 s.l. - linagliptinum - tabletki powlekane - 5 mg
sansik 5 mg tabletki powlekane
zentiva, k.s. - linagliptinum - tabletki powlekane - 5 mg
mounjaro
eli lilly nederland b.v. - tirzepatide - diabetes mellitus, type 2 - leki stosowane w cukrzycy - mounjaro is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance or contraindications- in addition to other medicinal products for the treatment of diabetes. for study results with respect to combinations, effects on glycaemic control and the populations studied, see sections 4. 4, 4. 5 i 5.
sitagliptin +pharma 100 mg tabletki powlekane
+pharma arzneimittel gmbh - sitagliptinum - tabletki powlekane - 100 mg
sitagliptin +pharma 25 mg tabletki powlekane
+pharma arzneimittel gmbh - sitagliptinum - tabletki powlekane - 25 mg
sitagliptin +pharma 50 mg tabletki powlekane
+pharma arzneimittel gmbh - sitagliptinum - tabletki powlekane - 50 mg
sitagliptin + metformin hydrochloride +pharma 50 mg + 1000 mg tabletki powlekane
+pharma arzneimittel gmbh - sitagliptini hydrochloridum monohydricum + metformini hydrochloridum - tabletki powlekane - 50 mg + 1000 mg
sitagliptin + metformin hydrochloride +pharma 50 mg + 850 mg tabletki powlekane
+pharma arzneimittel gmbh - sitagliptini hydrochloridum monohydricum + metformini hydrochloridum - tabletki powlekane - 50 mg + 850 mg
avaglim
smithkline beecham ltd - rosiglitazone glimepiride - diabetes mellitus, type 2 - leki stosowane w cukrzycy - avaglim jest wskazany w leczeniu pacjentów z cukrzycą typu 2, którzy nie są w stanie osiągnąć wystarczającej kontroli glikemicznej nad optymalną dawką monofloboroniamonu, i dla których metformina jest niewłaściwa z powodu przeciwwskazań lub nietolerancji.
eucreas
novartis europharm limited - вилдаглиптин, metformina chlorowodorek - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.